Patents by Inventor Michalina Adamski

Michalina Adamski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine for protection against HIV infections, process for preparing same and their use as diagnostic and agent immunotherapeutic agent
    Patent number: 5861243
    Abstract: Vaccine for protection against HIV infections, therapeutic agents for treatment subsequent to HIV infections, process for their preparation and their use; procedure for differentiation between HIV-2.sub.ALT type infections and HIV-2 infections defined by the prototype HIV-2.sub.ROD.Subject matter of the present invention are the virus HIV-2.sub.D205 as well as HIV-2 variants distinguishing from the HIV-2 prototypes of the type HIV-2.sub.ROD in that nucleotide sequence homology is less than 77%. Further, proteins and nucleic acids of HIV-2.sub.D205 and its variants for utilization as vaccines for protection against HIV infections, for geno- or immunotherapy, for establishing an animal model, and for differential diagnostics are part of this invention. Furthermore, the processes for preparing these vaccines, immunotherapeutic and diagnostic agents as well as their use are part of this invention.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: January 19, 1999
    Assignee: Chemotherapeutisches Forschunginstitut Georg Speyer-Haus Zu Frankfurt A.M.
    Inventors: Ursula Dietrich, Michalina Adamski, Hagen Von Briesen, Herbert Kuhnel, Helga Rubsamen-Waigmann
  • HIV-2 virus variants
    Patent number: 5677147
    Abstract: HIV-2 virus variants, namely virus HIV D194 and virus HIV D205, which can be cloned from the corresponding virus isolate HIV D194 (ECACC V 87122303) or from the infected cell line HUT 194 (ECACC V 87122306) or from the virus isolate HIV D205 (ECACC V 87122304), respectively, and their RNA or RNA-fragments and DNA and DNA-fragments derived therefrom and/or proteins and the use thereof for diagnostics and therapy.
    Type: Grant
    Filed: July 22, 1996
    Date of Patent: October 14, 1997
    Assignees: Qiagen GmbH, Chemotherapeutisches Forschunginstitut Georg-Speyer-Haus
    Inventors: Karsten Henco, Hagen von Briesen, Andreas Immelmann, Herbert Kuhnel, Ursula Dietrich, Helga Rubsamen-Waigmann, Michalina Adamski
  • HIV-2 virus variants
    Patent number: 5637455
    Abstract: HIV-2 virus variants, namely virus HIV D194 and virus HIV D205, which can be cloned from the corresponding virus isolate HIV D194 (ECACC V 87122303) or from the infected cell line HUT 194 (ECACC V 87122306) or from the virus isolate HIV D205 (ECACC V 87122304), respectively, and their RNA or RNA-fragments and DNA and DNA-fragments derived therefrom and/or proteins and the use thereof for diagnostics and therapy.
    Type: Grant
    Filed: December 14, 1994
    Date of Patent: June 10, 1997
    Assignees: Qiagen GmbH, Chemotherapeutisches Forschunginstitut Georg-Speyer-Haus
    Inventors: Karsten Henco, Hagen von Briesen, Andreas Immelmann, Herbert Kuhnel, Ursula Dietrich, Helga Rubsamen-Waigmann, Michalina Adamski